Navigation Links
Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
Date:2/14/2011

critical period in our history and has been a key architect of our return-to-growth strategy. I have enjoyed working with him and the Board as part of the planned succession process and look forward to working together to ensure a smooth and orderly transition."

"I am thrilled to lead Kendle through the next chapter in its growth," said Dr. Cutler. "As a result of Candace's leadership, we are poised for growth in the fastest-growing segment of outsourced clinical development services. Our focus is on differentiating Kendle through best-in-class delivery and innovative solutions leveraging creative patient access and retention approaches, cost-effective drug development models and emerging market capabilities. I look forward to continuing to work closely with Candace, our senior management team and our associates around the globe to deliver best-in-class clinical development solutions for our customers and exceptional value for our shareholders."

Dr. Cutler joined Kendle in 2009 as Senior Vice President and COO and since that time has provided global leadership for the Company's worldwide Late Stage operations. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management – Europe; and Vice President, Oncology – Europe as well as regional leadership positions in South Africa and Australia.  Prior to joining Quintiles Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. He holds a Doctorate in Philosophy from the University of Sydney in Sydney, Australia, and a Master's of Business Administration from the University of Birmingham in Birmingham, England. Dr. Cutler represents Kendle on the Board of Directors of the Association of Clinical Research Organizations (ACRO).

Assuming the role of Senior Vice President and COO from Dr. Cutler will be Ja
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
2. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
3. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
4. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
5. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
6. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
7. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
8. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
9. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
10. Kendle Launches New Global Biostatistics Infrastructure
11. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... For the past 15 years, there has been an ... U.S. alone (U.S. Census Bureau 2012). Of course, not every accident ... there are quite a few where the car occupants can get ... the seatbelt release button or occupant injury. One ... in their lifetime but may still be "lucky" enough to come ...
(Date:3/2/2015)... Following announcements from both Novartis and ... Inc. (NASDAQ:  ARRY) today announced the completion of ... Novartis.  Along with global ownership of both assets, ... million from Novartis. Ron Squarer, Chief ... the Novartis-GSK transaction, Array now owns both binimetinib ...
(Date:3/2/2015)... NEW YORK , March 2, 2015 ... HealthCare are kicking off the 2015 One ... The month-long national campaign will raise awareness and funds ... the more than one million colorectal cancer survivors living ... fight this disease with great strength and courage every ...
Breaking Medicine Technology:New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5
... Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ), ... today that the company is partnering with The ... Houston, Texas to launch a prospective,clinical study to ... in the study will be randomly assigned to ...
... announces data presented at AACR-NCI-EORTC ... ... (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a,wholly-owned ... candidates during the 19th annual AACR-NCI-EORTC Symposium. "These studies show ...
Cached Medicine Technology:M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
(Date:3/2/2015)... Portland, OR (PRWEB) March 02, 2015 ... its plan to remake American healthcare. Zoom will ... include 28 neighborhood clinics and advanced care studios ... mental health, emergency services, specialty care and outpatient ... provide on-demand access to almost all healthcare needs ...
(Date:3/2/2015)... 2015 Burns Engineering's Lab-to-Lab Calibration ... Secondary Standard Platinum Resistance Thermometers (SSPRTs) and industrial ... or less . . . guaranteed. ... (Lab Code 200706-0), ISO 9001 and 17025 Certified ... is -196°C to 500°C, both ITS-90 and Callendar-van ...
(Date:3/2/2015)... 2015 Representatives with BNatrl ( ... launched a multivitamin supplement that’s specifically designed for ... for BNatrl, said the multivitamin, which launched Jan. ... other world-class athletes. , "Being an avid marathon ... whole food multivitamin to improve my performance,” said ...
(Date:3/2/2015)... Houston, TX (PRWEB) March 02, 2015 ... a lot easier thanks to the success of ... making meal planning easy and delicious for thousands ... overwhelmingly positive customer feedback by expanding to offer ... Traditional Tastes, which features seasonally appropriate classic recipes ...
(Date:3/2/2015)... A true renaissance man—some might call him a “Jack ... band Khazad Doom, has long inspired his countless fans. That ... odds. His motto throughout his life has always been “Got ... before him. And that attitude, born amidst the turmoil and ... a new generation. , As Eadon knows, when you have ...
Breaking Medicine News(10 mins):Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3
... tricked body, slowed down metabolism in rats , , MONDAY, ... popular artificial sweetener has the unexpected and unwelcome effect ... that saccharin altered the ability of rats to control ... trade group scoffed at the findings, saying they don,t ...
... Progress in Women,s Cancer, Theme, Spotlights Four ... Cancers, CHICAGO, Feb. 11 The Society ... Meeting on Women,s Cancer March,9-12 at the Tampa ... will feature more than 350 scientific presentations,lectures, workshops, ...
... ... ... ... Tuesday, February 12, 2008, The,James E. Marshall OCD Foundation, which benefits genetic research and,awareness for Obsessive-Compulsive Disorder, will ...
... identified a key protein target that may be a crucial ... new therapies to treat pneumonia, the leading killer of children ... of the Division of Pediatric Pulmonary Medicine, Allergy and Immunology ... a protein known as interleukin 22 (IL-22) in the immune ...
... German . , Anyone trying to build sandcastles ... and imagination, but not an instruction manual. The water ... of the sand. This observation, which is borne out ... with water content of just 3%, the fluid inside ...
... Directions, Inc. (MDI),an independent digital medical education and ... program dealing with the,management of chronic pain has ... lectures by national experts., The study, which ... and Stroke (NINDS), was reported February 5, 2008 ...
Cached Medicine News:Health News:Sugar Substitutes May Contribute to Weight Gain 2Health News:Sugar Substitutes May Contribute to Weight Gain 3Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 2Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 3Health News:Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications 2Health News:Children's Hospital scientists identify possible target for prevention and treatment of pneumonia 2Health News:Why anyone can make a sandcastle 2Health News:Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: